Liang et al. hypothesized that this expression correlation was a direct result of HCP5 upregulation of ST6GAL2, driving FTC carcinogenesis; this places a function for HCP5 as a ceRNA molecules. The gene discussed is ST6GAL2; the disease is thyroid cancer, nonmedullary, 2.